Although feasibility testing was conducted with a group of adults with T1D using MDIs insulin therapy prior to study, greater investment in user involving in the development of the study interventions might have further improved adherence and, potentially, glycemic outcomes. The gene discussed is INS; the disease is type 1 diabetes mellitus.